These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quantification of the pathological changes in the temporal lobe of patients with a novel neurofilamentopathy: neurofilament inclusion disease (NID). Cairns NJ; Armstrong RA Clin Neuropathol; 2004; 23(3):107-12. PubMed ID: 15200288 [TBL] [Abstract][Full Text] [Related]
6. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Kövari E; Gold G; Giannakopoulos P; Bouras C Acta Neuropathol; 2004 Sep; 108(3):207-12. PubMed ID: 15170577 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous inclusions in neurofilament inclusion disease. Uchikado H; Li A; Lin WL; Dickson DW Neuropathology; 2006 Oct; 26(5):417-21. PubMed ID: 17080718 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Parkkinen L; Kauppinen T; Pirttilä T; Autere JM; Alafuzoff I Ann Neurol; 2005 Jan; 57(1):82-91. PubMed ID: 15562510 [TBL] [Abstract][Full Text] [Related]
9. Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. Pirici D; Vandenberghe R; Rademakers R; Dermaut B; Cruts M; Vennekens K; Cuijt I; Lübke U; Ceuterick C; Martin JJ; Van Broeckhoven C; Kumar-Singh S J Neuropathol Exp Neurol; 2006 Mar; 65(3):289-301. PubMed ID: 16651890 [TBL] [Abstract][Full Text] [Related]
10. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851 [TBL] [Abstract][Full Text] [Related]
11. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin. Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]